Results 221 to 230 of about 3,364,808 (342)

Fluoroquinolone‐Associated Psychiatric and Ocular Adverse Events: A Disproportionality Analysis Using Real‐World Data From FAERS (2011–2024)

Pharmacology Research &Perspectives, Volume 14, Issue 1, February 2026.
This pharmacovigilance study identifies a wide range of rapid‐onset neuropsychiatric and ocular adverse effects linked to fluoroquinolones (FQ). Disproportionality analysis revealed a disproportionate reporting of suicidal ideation and visual impairment following FQ treatment, emphasizing the urgent need for cautious prescribing and strengthened safety
Hau‐Tak Chau, Ngan Pan Bennett Au
wiley   +1 more source

Direct effect of antipsychotic agent on corticoid production in adrenal cortex.Study using primary culture of cattle adrenocortical cell.

, 1991
Noboru Nakamichi
openalex   +2 more sources

Effects of licence change on prescribing and poisons enquiries for antipsychotic agents in England and Scotland [PDF]

, 2003
D. Nicholas Bateman, Anthony Good, Ronak Afshari, Catherine Kelly   +3 more
openalex   +1 more source

Duplicate Prescription Patterns in Patients With Substance Use Disorders

Pharmacology Research &Perspectives, Volume 14, Issue 1, February 2026.
ABSTRACT This study sought to investigate the frequency and characteristics of duplicate prescriptions (DPs) in psychiatric inpatients with substance use disorders using a DP classification that differentiates between appropriate DPs (ADPs) and potentially inappropriate DPs (PIDPs). The study was conducted as a monocentric retrospective cross‐sectional
Johannes Heck, Benjamin Krichevsky, Martin Schulze Westhoff, Konstantin Fritz Jendretzky, Martin Klietz, Stephan Greten, Alexander Glahn, Stefan Bleich, Sebastian Schröder   +8 more
wiley   +1 more source

Delirium associated with trifluridine/tipiracil in an elderly patient with metastatic colorectal cancer: A case report. [PDF]

PCN Rep
Otani K, Kinoshita T, Shindo R, Shibuya N.   +3 more
europepmc   +1 more source

The medicinal chemistry of 2-aminotetralin-derived benzamides: a novel class of potential atypical antipsychotic agents

, 1998
Evert Homan
openalex   +1 more source

Synergistic Effects of Olanzapine and Other Antipsychotic Agents in Combination with Fluoxetine on Norepinephrine and Dopamine Release in Rat Prefrontal Cortex [PDF]

, 2000
Wei Zhang
openalex   +1 more source

Aripiprazole, a novel antipsychotic agent: dopamine D2 receptor partial agonist.

Journal of Medical Investigation, 2005
T. Hirose, T. Kikuchi
semanticscholar   +1 more source

The Risk Factors and Mortality Among Patients With Different Combination Patterns of Opioids and Benzodiazepines: A Retrospective Study

Pharmacology Research &Perspectives, Volume 14, Issue 1, February 2026.
ABSTRACT The concurrent use of opioids and benzodiazepines (BZDs) has raised safety concerns due to increased risks of respiratory depression and death. To evaluate mortality risks linked to different patterns of co‐prescription, we conducted a retrospective cohort study using data from a private hospital system between 2008 and 2018.
Fang‐Yu Su, Ming‐Che Tsai, Yee‐Yung Ng, Shiao‐Chi Wu   +3 more
wiley   +1 more source

The Use of Long-Acting Injectables for People with Schizophrenia: Consensus Panel Recommendations for Overcoming Barriers and Implementing Treatment. [PDF]

Neurol Ther
Kane JM, Agid O, Castle DJ, Citrome L, Fagiolini A, Kishimoto T, Larrauri CA, Leucht S, Rubio JM, Sajatovic M, Schooler N, Correll CU.   +11 more
europepmc   +1 more source